Teresa N Head, OD - Medicare Optometrist in Coventry, RI

Teresa N Head, OD is a medicare enrolled "Optometrist" provider in Coventry, Rhode Island. She went to Pennsylvania College Of Optometry and graduated in 2008 and has 16 years of diverse experience with area of expertise as Optometry. She is a member of the group practice Giulio G Diamante Md Inc and her current practice location is 1193 Tiogue Ave, Coventry, Rhode Island. You can reach out to her office (for appointments etc.) via phone at (401) 823-8200.

Teresa N Head is licensed to practice in Massachusetts (license number 4701) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1851547632.

Contact Information

Teresa N Head, OD
1193 Tiogue Ave,
Coventry, RI 02816-6122
(401) 823-8200
Not Available



Healthcare Provider's Profile

Full NameTeresa N Head
GenderFemale
SpecialityOptometry
Experience16 Years
Location1193 Tiogue Ave, Coventry, Rhode Island
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Teresa N Head attended and graduated from Pennsylvania College Of Optometry in 2008
  NPI Data:
  • NPI Number: 1851547632
  • Provider Enumeration Date: 08/13/2008
  • Last Update Date: 04/01/2010
  Medicare PECOS Information:
  • PECOS PAC ID: 9032277124
  • Enrollment ID: I20100910000243

Medical Identifiers

Medical identifiers for Teresa N Head such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1851547632NPI-NPPES
110079568/AMedicaidMA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 4701 (Massachusetts)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Giulio G Diamante Md Inc77190987304

News Archive

New Locilex microbiology data presented at ICAAC/ICC 2015 scientific conference

Dipexium Pharmaceuticals, Inc., a late-stage pharmaceutical company focused on the development and commercialization of Locilex (pexiganan cream 0.8%), and research collaborators, JMI Laboratories, announced that new Locilex microbiology data were presented at the American Society for Microbiology's Interscience Conference of Antimicrobial Agents and Chemotherapy and International Society of Chemotherapy's International Congress of Chemotherapy and Infection (ICAAC/ICC 2015) scientific conference in San Diego, California, September 17-21, 2015.

CRT, ICR sign deal with ZoBio to discover and develop cancer drugs

Cancer Research Technology and The Institute of Cancer Research have signed a deal with Dutch drug discovery company, ZoBio BV, to discover and develop drugs to block a DNA repair target which may play a role in cancer cell survival.

CSL Behring supports World Federation of Hemophilia with 1 million IUs of von Willebrand factor/Factor VIII

CSL Behring has donated more than 1 million international units (IU) of von Willebrand factor (VWF)/Factor VIII (FVIII) replacement medication to patients through the World Federation of Hemophilia (WFH). The donation supports WFH's progress in improving the diagnosis and treatment of bleeding disorders in developing countries through its Global Alliance for Progress (GAP) program.

Study highlights need to focus on healthcare transition period in young patients with type 2 diabetes

Youth-onset type 2 diabetes is increasing globally as a result of pediatric obesity. A new study in Diabetic Medicine shows that young adults with type 2 diabetes have substantially worse blood sugar control and loss to follow-up during healthcare transition from pediatric to adult health systems. This is the first study of healthcare transition effects in youth-onset type 2 diabetes.

HHS approves Medicaid expansion for Minnesota

Gov. Mark Dayton's plan to expand the state's Medicaid rolls by 95,000 people has been approved by federal authorities, his office said Thursday. The move, which begins March 1, will provide health insurance to 12,000 low-income adults who previously were uninsured, and broader coverage at lower cost to another 83,000 who received care under two state-funded programs, MinnesotaCare and General Assistance Medical Care (2/17).

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Teresa N Head allows following entities to bill medicare on her behalf.
Provider NameGiulio G Diamante Md Inc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1770761660
PECOS PAC ID: 7719098730
Enrollment ID: O20120613000024

News Archive

New Locilex microbiology data presented at ICAAC/ICC 2015 scientific conference

Dipexium Pharmaceuticals, Inc., a late-stage pharmaceutical company focused on the development and commercialization of Locilex (pexiganan cream 0.8%), and research collaborators, JMI Laboratories, announced that new Locilex microbiology data were presented at the American Society for Microbiology's Interscience Conference of Antimicrobial Agents and Chemotherapy and International Society of Chemotherapy's International Congress of Chemotherapy and Infection (ICAAC/ICC 2015) scientific conference in San Diego, California, September 17-21, 2015.

CRT, ICR sign deal with ZoBio to discover and develop cancer drugs

Cancer Research Technology and The Institute of Cancer Research have signed a deal with Dutch drug discovery company, ZoBio BV, to discover and develop drugs to block a DNA repair target which may play a role in cancer cell survival.

CSL Behring supports World Federation of Hemophilia with 1 million IUs of von Willebrand factor/Factor VIII

CSL Behring has donated more than 1 million international units (IU) of von Willebrand factor (VWF)/Factor VIII (FVIII) replacement medication to patients through the World Federation of Hemophilia (WFH). The donation supports WFH's progress in improving the diagnosis and treatment of bleeding disorders in developing countries through its Global Alliance for Progress (GAP) program.

Study highlights need to focus on healthcare transition period in young patients with type 2 diabetes

Youth-onset type 2 diabetes is increasing globally as a result of pediatric obesity. A new study in Diabetic Medicine shows that young adults with type 2 diabetes have substantially worse blood sugar control and loss to follow-up during healthcare transition from pediatric to adult health systems. This is the first study of healthcare transition effects in youth-onset type 2 diabetes.

HHS approves Medicaid expansion for Minnesota

Gov. Mark Dayton's plan to expand the state's Medicaid rolls by 95,000 people has been approved by federal authorities, his office said Thursday. The move, which begins March 1, will provide health insurance to 12,000 low-income adults who previously were uninsured, and broader coverage at lower cost to another 83,000 who received care under two state-funded programs, MinnesotaCare and General Assistance Medical Care (2/17).

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Teresa N Head is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Teresa N Head, OD
1193 Tiogue Ave,
Coventry, RI 02816-6122

Ph: (401) 823-8200
Teresa N Head, OD
1193 Tiogue Ave,
Coventry, RI 02816-6122

Ph: (401) 823-8200

News Archive

New Locilex microbiology data presented at ICAAC/ICC 2015 scientific conference

Dipexium Pharmaceuticals, Inc., a late-stage pharmaceutical company focused on the development and commercialization of Locilex (pexiganan cream 0.8%), and research collaborators, JMI Laboratories, announced that new Locilex microbiology data were presented at the American Society for Microbiology's Interscience Conference of Antimicrobial Agents and Chemotherapy and International Society of Chemotherapy's International Congress of Chemotherapy and Infection (ICAAC/ICC 2015) scientific conference in San Diego, California, September 17-21, 2015.

CRT, ICR sign deal with ZoBio to discover and develop cancer drugs

Cancer Research Technology and The Institute of Cancer Research have signed a deal with Dutch drug discovery company, ZoBio BV, to discover and develop drugs to block a DNA repair target which may play a role in cancer cell survival.

CSL Behring supports World Federation of Hemophilia with 1 million IUs of von Willebrand factor/Factor VIII

CSL Behring has donated more than 1 million international units (IU) of von Willebrand factor (VWF)/Factor VIII (FVIII) replacement medication to patients through the World Federation of Hemophilia (WFH). The donation supports WFH's progress in improving the diagnosis and treatment of bleeding disorders in developing countries through its Global Alliance for Progress (GAP) program.

Study highlights need to focus on healthcare transition period in young patients with type 2 diabetes

Youth-onset type 2 diabetes is increasing globally as a result of pediatric obesity. A new study in Diabetic Medicine shows that young adults with type 2 diabetes have substantially worse blood sugar control and loss to follow-up during healthcare transition from pediatric to adult health systems. This is the first study of healthcare transition effects in youth-onset type 2 diabetes.

HHS approves Medicaid expansion for Minnesota

Gov. Mark Dayton's plan to expand the state's Medicaid rolls by 95,000 people has been approved by federal authorities, his office said Thursday. The move, which begins March 1, will provide health insurance to 12,000 low-income adults who previously were uninsured, and broader coverage at lower cost to another 83,000 who received care under two state-funded programs, MinnesotaCare and General Assistance Medical Care (2/17).

Read more News

› Verified 6 days ago


Optometrist in Coventry, RI

Dr. Richard S Liner, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 860 Tiogue Ave, Coventry, RI 02816
Phone: 401-828-2020    Fax: 401-828-4482
Dr. Mark G Blasbalg, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1193 Tiogue Ave, Coventry, RI 02816
Phone: 401-823-8200    Fax: 401-826-8708
Liane Carley Prytula, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1193 Tiogue Ave, Coventry, RI 02816
Phone: 401-823-8200    
Coventry Eye Care Associates & Optical Center
Optometrist
Medicare: Medicare Enrolled
Practice Location: 860 Tiogue Ave, Coventry, RI 02816
Phone: 401-828-2020    Fax: 401-828-4482
Acuity Vision & Eyewear Center
Optometrist
Medicare: Medicare Enrolled
Practice Location: 1193 Tiogue Ave, Coventry, RI 02816
Phone: 401-823-8200    Fax: 401-826-8708
Dr. Stephanie Ann Schultz, OD
Optometrist
Medicare: May Accept Medicare Assignments
Practice Location: 112 Bramble Bush Rd, Coventry, RI 02816
Phone: 401-397-2597    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.